• By Shaji Kumar, MD, Professor of Medicine, Hematology, Mayo Clinic  |  Nov 1, 2017

    Multiple Myeloma: Promising New Therapies, But Challenges Remain

    This week, our series on multiple myeloma continues as we talk about immunotherapies and other promising new treatments with Shaji Kumar, MD. Dr. Kumar is a professor of medicine in the division of hematology at Mayo Clinic, where he chairs the myeloma group across all three Mayo sites. Dr. Kumar…more.

    Categories: General, Multiple Myeloma
  • By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Oct 18, 2017

    The Multiple Myeloma Landscape

    Editor’s Note: This article originally appeared in Biotech Primer Weekly. For more of the science behind the headlines, please subscribe. Multiple myeloma is a cancer formed by a type of white blood cell called a plasma cell. These cells are the antibody-producing cells of our immune system and play a…more.

    Categories: General, Multiple Myeloma